Socialiya - Entertainment. Knowledge. Community.
Allogene Therapeutics’ CAR-T treatment eliminates residual cancer cells in B-cell lymphoma patients

Allogene Therapeutics said Monday that its off-the-shelf CAR-T treatment eliminated residual cancer...

BUSINESS NEWS April 13, 2026

Allogene Therapeutics’ CAR-T treatment eliminates residual cancer cells in B-cell lymphoma patients

Allogene Therapeutics said Monday that its off-the-shelf CAR-T treatment eliminated residual cancer cells in patients with B-cell lymphoma three times...

19 views 0 likes 0 comments
Share:
Allogene Therapeutics said Monday that its off-the-shelf CAR-T treatment eliminated residual cancer cells in patients with B-cell lymphoma three times...

Author: statnews.com

Read Original Article

Related News

Advertisement
socialiya
Advertisement
APNA POS
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
APNA POS
Advertisement
APNA POS
Advertisement
socialiya